Skip to main content
. Author manuscript; available in PMC: 2009 Apr 15.
Published in final edited form as: Cancer Res. 2008 Apr 15;68(8):2632–2640. doi: 10.1158/0008-5472.CAN-07-5460

Figure 4.

Figure 4

Bay 11-7082 and rapamycin suppressed bile acid–induced esophageal tumor anchorage-independent growth. A, CDCA enhanced the anchorage-independent growth abilities of SEG-1 EAC cancer cells in soft agar. B, quantitative result of A. CDCA-induced SEG-1 and BE3 EAC cancer cells’ soft agar growth ability (P < 0.05). The enhanced anchorage-independent growth could be inhibited by Bay 11-7082 and rapamycin (P < 0.001).